Clinical Trial Update: A Study to Determine the Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Dark Circles [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating the safety and efficacy of autologous human platelet lysate (HPL) for treating periorbital hyperpigmentation (dark circ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periorbital Hyperpigmentation

Drugs mentioned

• Autologous Human Platelet Lysate (HPL) (platelet lysate)

Snippet

Sponsor: Kasiak Research Pvt. Ltd. | Conditions: Periorbital Hyperpigmentation (Dark Circles) | Phase 1, Phase 2 | Status: UNKNOWN